Skip to main content

Animations

MJFF Publications

2931 - 2940 of 6403 Results
Title
Year
  • Year
  • 2011
  • 2012
  • 2012
  • 2012
  • 2016
  • 2015
  • 2011
  • 2011
  • 2007
  • 2010
  • Summary Details
    OPEN
    Title: Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With Aβ Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue
    Journal Name: Alzheimer Disease & Associated Disorders
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/wad.0b013e31821300bc
    Citation Count: 128
  • Summary Details
    OPEN
    Title: Randomized Clinical Trial of 3 Types of Physical Exercise for Patients With Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.646
    Citation Count: 386
  • Summary Details
    OPEN
    Title: Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease [RETIRED]
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e318263c443
    Citation Count: 165
  • Summary Details
    OPEN
    Title: Altered Pharyngeal Muscles in Parkinson Disease
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/nen.0b013e318258381b
    Citation Count: 136
  • Summary Details
    OPEN
    Title: Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations
    Journal Name: Journal of Cerebral Blood Flow & Metabolism
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/0271678x16637880
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Binding to serine 65‐phosphorylated ubiquitin primes Parkin for optimal PINK 1‐dependent phosphorylation and activation
    Journal Name: EMBO reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embr.201540352
    Citation Count: 230
  • Summary Details
    OPEN
    Title: Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e318237f649
    Citation Count: 56
  • Summary Details
    OPEN
    Title: GFAP mutations, age at onset, and clinical subtypes in Alexander disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182309f72
    Citation Count: 230
  • Summary Details
    OPEN
    Title: Murine models of acute neuronopathic Gaucher disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0708086104
    Citation Count: 188
  • Summary Details
    OPEN
    Title: TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820a0e3b
    Citation Count: 235
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.